People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

A new study says the health of American children has gotten worse across the board in the last 17 years. Published in the ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

The coverage change applies to CVS Caremark’s most common formulary template, which represents between 25 and 30 million individuals overall. When the choice was available, the subset of members who ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

Beginning July 1, the company’s Pharmacy Benefit Manager (“PBM”), CVS Caremark, will list Wegovy — the flagship GLP-1-based weight loss medication from Novo Nordisk NVO — on its largest ...